Attached files
file | filename |
---|---|
8-K - FORM 8-K - AURORA DIAGNOSTICS HOLDINGS LLC | d727105d8k.htm |
Exhibit 99.1
First Quarter 2014 Results and Investor Conference Call
PALM BEACH GARDENS, FL (May 14, 2014) Aurora Diagnostics Holdings, LLC announced that it will hold a conference call to review its results for the quarter ended March 31, 2014, on Tuesday, May 20, 2014, at 12:00 p.m. Eastern Time. The call may be accessed by dialing (877) 561-2748 for U.S. callers or (720) 545-0044 for international callers. Please reference conference ID# 46654833.
The Company will provide a live internet webcast of the conference call, as well as an archived replay, all of which can be accessed from the Companys Investor Relations page at www.auroradx.com. In addition, a telephonic replay of the conference call will be available through midnight on Tuesday, May 27, 2014 and can be accessed by dialing (855) 859-2056 (toll free) or (404) 537-3406. Please reference conference ID# 46654833.
About Aurora Diagnostics
Aurora Diagnostics is a specialized laboratory company focused on anatomic pathology with 19 primary community-based laboratory locations in the United States. With over 100 licensed physicians, Aurora Diagnostics provides high quality diagnostics and testing information for the patients of its primary referral sources, dermatologists, OB/GYN professionals, gastroenterologists, urologists, general surgeons, oncologists and 58 community-based hospitals. Auroras Research Institute provides expanded opportunities for pharmaceutical and diagnostic research and development organizations to leverage Auroras expertise and resources in order to further the advancement of patient care.
For additional information regarding the Company and the services it provides, visit the Companys website located at http://www.auroradx.com.
Investor Relations Contact
For questions and inquiries regarding the foregoing, please contact John DAchille, Director of Financial Reporting, at jdachille@auroradx.com.